Uehara Y, Kawabata Y, Shirahase H, Wada K, Hashizume Y, Morishita S, Numabe A, Iwai J
2nd Department of Medicine, University of Tokyo, Japan.
J Cardiovasc Pharmacol. 1993;22 Suppl 6:S42-6.
In addition to the hemodynamic components, the roles of various humoral factors have been emphasized in the progression of vascular and renal injury in hypertension. Radical scavenging properties have attracted much attention in this field. This article discusses the implication of antioxidant properties of the antihypertensive diuretic indapamide on renal injury in Dahl salt-sensitive (Dahl S) rats. Hydroxyl radicals, oxygen radicals toxic to cellular membranes, are eradicated by indapamide in different assay systems, e.g., reduction of alpha-alpha-diphenyl-beta-picrylhydrazyl, rat brain homogenate, or xanthine-xanthine oxidase systems. Such antioxidant effects of indapamide are primarily due to inhibition of lipid peroxidation induced by hydroxyl radicals, and this mechanism may stimulate prostacyclin generation through activation of prostacyclin synthase. In fact, the antioxidant properties of indapamide are well expressed in vivo as well; indapamide treatment reduced oxygen radicals in the kidney of Dahl S rats with hypertension. This was accompanied by a functional improvement of the kidney; decreases in urinary protein and n-acetylglucosaminidase excretion and an increase in glomerular filtration rate were observed. In addition, indapamide morphologically ameliorated the renal injury, and decreased glomerular sclerosis score, arterial injury, and renal tubular injury. Trichloromethiazide reduces blood pressure similar to that produced by indapamide. However, trichloromethiazide did not lead to reduction of oxygen radicals in the kidney, and did not improve the functional disturbance or morphological injury seen in Dahl S rats. These results indicate that indapamide has antioxidant properties, and in addition to blood pressure reduction, such radical scavenging effects may contribute to its beneficial effects on renal function in vivo.
除血液动力学因素外,各种体液因子在高血压血管和肾脏损伤进展中的作用也受到了重视。自由基清除特性在该领域引起了广泛关注。本文讨论了降压利尿剂吲达帕胺的抗氧化特性对 Dahl 盐敏感(Dahl S)大鼠肾脏损伤的影响。羟基自由基是对细胞膜有毒性的氧自由基,在不同的检测系统中,如在α-α-二苯基-β-苦味酰肼还原、大鼠脑匀浆或黄嘌呤-黄嘌呤氧化酶系统中,吲达帕胺可清除这些自由基。吲达帕胺的这种抗氧化作用主要是由于抑制了羟基自由基诱导的脂质过氧化,并且这种机制可能通过激活前列环素合酶来刺激前列环素的生成。事实上,吲达帕胺的抗氧化特性在体内也有很好的体现;吲达帕胺治疗可降低高血压 Dahl S 大鼠肾脏中的氧自由基。这伴随着肾脏功能的改善;观察到尿蛋白和 N-乙酰葡糖胺酶排泄减少,肾小球滤过率增加。此外,吲达帕胺在形态学上改善了肾脏损伤,并降低了肾小球硬化评分、动脉损伤和肾小管损伤。三氯噻嗪降低血压的效果与吲达帕胺相似。然而,三氯噻嗪并未导致 Dahl S 大鼠肾脏中氧自由基的减少,也未改善其功能紊乱或形态学损伤。这些结果表明,吲达帕胺具有抗氧化特性,除了降低血压外,这种自由基清除作用可能有助于其在体内对肾功能产生有益影响。